Mechanisms controlling pathogenesis and survival of leukemic stem cells

Oncogene

Volumn 23, Issue 43 REV. ISS. 6, 2004, Pages 7178-7187

  Jordan, Craig T ^a   Guzman, Monica L ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Leukemia; Leukemogenesis; LSC; Myeloid; NF B; Stem cell

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CD123 ANTIGEN; CD33 ANTIGEN; CYTARABINE; DAUNORUBICIN; FLUOROURACIL; FREE RADICAL; GEMTUZUMAB OZOGAMICIN; IDARUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN P21; PROTEIN P53; ONCOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL MODEL; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CYTOGENETICS; DNA STRAND BREAKAGE; GENE EXPRESSION REGULATION; GENOTOXICITY; HEMATOPOIETIC STEM CELL; HOMEOBOX; HOXA9 GENE; LEUKEMIA; LEUKEMIC STEM CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SELF RENEWAL; STEM CELL; TUMOR SUPPRESSOR GENE; ACUTE DISEASE; ANIMAL; BIOLOGICAL MODEL; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL DIVISION; CELL TRANSFORMATION; CYTOLOGY; DRUG DESIGN; EXPERIMENTAL LEUKEMIA; GENETICS; HUMAN; IMMUNOPHENOTYPING; MYELOID LEUKEMIA; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA; MAMMALIA;

ACUTE DISEASE; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIVISION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DRUG DESIGN; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, MYELOID; MICE; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; ONCOGENE PROTEINS, FUSION; SIGNAL TRANSDUCTION; TUMOR STEM CELLS;

EID: 6044234531     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207935     Document Type: Review

References (93)

1. Akashi K, Traver D, Miyamoto T and Weissman IL. (2000). Nature, 404, 193-197.
2. Baldwin AS. (1996). Annu. Rev. Immunol., 14, 649-683.
3. Birkenkamp KU, Geugien M, Schepers H, Westra J, Lemmink HH and Vellenga E. (2004). Leukemia, 18, 103-112.
4. Blair A, Hogge DE, Ailles LE, Lansdorp PM and Sutherland HJ. (1997). Blood, 89, 3104-3112.
5. Blair A, Hogge DE and Sutherland HJ. (1998). Blood, 92, 4325-4335.
6. Blair A and Sutherland HJ. (2000). Exp. Hematol., 28, 660-671.
7. Bonnet D and Dick JE. (1997). Nat. Med., 3, 730-737.
8. Brach MA, Kharbanda SM, Herrmann F and Kufe DW. (1992). Mol. Pharmacol., 41, 60-63.
9. Braun BS, Tuveson DA, Kong N, Le DT, Kogan SC, Rozmus J, Le Beau MM, Jacks TE and Shannon KM. (2004). Proc. Natl. Acad. Sci. USA, 101, 597-602.
10. Bruce WR and Gaag H. (1963). Nature, 199, 79-80.
11. Chan IT, Kutok JL, Williams IR, Cohen S, Kelly L, Shigematsu H, Johnson L, Akashi K, Tuveson DA, Jacks T and Gilliland DG. (2004). J. Clin. Invest., 113, 528-538.
12. Charrad RS, Li Y, Delpech B, Balitrand N, Clay D, Jasmin C, Chomienne C and Smadja-Joffe F. (1999). Nat. Med., 5, 669-676.
13. Chaudhary PM and Roninson IB. (1991). Cell, 66, 85-94.
14. Costello RT, Mallet F, Gaugler B, Sainty D, Arnoulet C, Gastaut JA and Olive D. (2000). Cancer Res., 60, 4403-4411.
15. Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML and Weissman IL. (2003). Genes Dev., 17, 3029-3035.
16. Cuenco GM and Ren R. (2001). Oncogene, 20, 8236-8248.
17. Dash A and Gilliland DG. (2001). Best. Pract. Res. Clin. Haematol., 14, 49-64.
18. Dash AB, Williams IR, Kutok JL, Tomasson MH, Anastasiadou E, Lindahl K, Li S, Van Etten RA, Borrow J, Housman D, Druker B and Gilliland DG. (2002). Proc. Natl. Acad. Sci. USA, 99, 7622-7627.
19. de Guzman CG, Warren AJ, Zhang Z, Gartland L, Erickson P, Drabkin H, Hiebert SW and Klug CA. (2002). Mol. Cell. Biol., 22, 5506-5517.
20. Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L, Hicklin DJ, Tateno M, Bohlen P, Moore MA and Rafii S. (2001). Proc. Natl. Acad. Sci. USA, 98, 10857-10862.
21. Dick JE. (1996). Semin. Immunol., 8, 197-206.
22. Dosil M, Wang S and Lemischka IR. (1993). Mol. Cell. Biol., 13, 6572-6585.
23. Fialkow PJ, Gartler SM and Yoshida A. (1967). Proc. Natl. Acad. Sci. USA, 58, 1468-1471.
24. Fialkow PJ, Jacobson RJ and Papayannopoulou T. (1977). Am. J. Med., 63, 125-130.
25. Foulds L. (1969). Neoplastic Development. Academic Press: London.
26. Foulds L. (1975). Neoplastic Development. Academic Press: London.
27. Gilliland DG and Griffin JD. (2002). Blood, 100, 1532-1542.
28. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES. (1999). Science, 286, 531-537.
29. Graham SM, Jorgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L and Holyoake TL. (2002). Blood, 99, 319-325.
30. Guan Y, Gerhard B and Hogge DE. (2003). Blood, 101, 3142-3149.
31. Gutteridge JM and Quinlan GJ. (1985). Biochem. Pharmacol., 34, 4099-4103.
32. Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM and Jordan CT. (2001a). Blood, 98, 2301-2307.
33. Guzman ML, Swiderski CF, Howard DS, Grimes BA, Rossi RM, Szilvassy SJ and Jordan CT. (2002). Proc. Natl. Acad. Sci. USA, 99, 16220-16225.
34. Guzman ML, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Phillips GL and Jordan CT. (2001b). Blood, 97, 2177-2179.
35. Hamann PR, Hinman LM, Hollander I, Beyer CF, Lindh D, Holcomb R, Hallett W, Tsou HR, Upeslacis J, Shochat D, Mountain A, Flowers DA and Bernstein I. (2002). Bioconjug. Chem., 13, 47-58.
36. Harrison DE and Lerner CP. (1991). Blood, 78, 1237-1240.
37. Hazlehurst LA and Dalton WS. (2001). Cancer Metast. Rev., 20, 43-50.
38. Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T, Munshi N, Dang L, Castro A, Palombella V, Adams J and Anderson KC. (2002). J. Biol. Chem., 277, 16639-16647.
39. Holyoake T, Jiang X, Eaves C and Eaves A. (1999). Blood, 94, 2056-2064.
40. Holyoake TL, Jiang X, Drummond MW, Eaves AC and Eaves CJ. (2002). Leukemia, 16, 549-558.
41. Hope KJ, Jin L and Dick JE. (2004). Nat. Immunol., 5, 738-743.
42. Jin L, Hope KJ, Dick JE and Smadja-Joffe F. (2003). Blood, 102, 622a.
43. Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, Meyerrose T, Rossi R, Grimes B, Rizzieri DA, Luger SM and Phillips GL. (2000). Leukemia, 14, 1777-1784.
44. Kamps MP and Baltimore D. (1993). Mol. Cell. Biol., 13, 351-357.
45. Kelly LM, Liu Q, Kutok JL, Williams IR, Boulton CL and Gilliland DG. (2002). Blood, 99, 310-318.
46. Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T and Sauvageau G. (2001). EMBO J., 20, 350-361.
47. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and Dick JE. (1994). Nature, 367, 645-648.
48. Laurent G and Jaffrezou JP. (2001). Blood, 98, 913-924.
49. Lavau C, Du C, Thirman M and Zeleznik-Le N. (2000a). EMBO J., 19, 4655-4664.
50. Lavau C, Luo RT, Du C and Thirman MJ. (2000b). Proc. Natl. Acad. Sci. USA, 97, 10984-10989.
51. Lawrence HJ, Rozenfeld S, Cruz C, Matsukuma K, Kwong A, Komuves L, Buchberg AM and Largman C. (1999). Leukemia, 13, 1993-1999.
52. Lemischka IR, (1997). Stem Cells, 15 (Suppl 1), 63-68.
53. Lessard J and Sauvageau G. (2003). Nature, 423, 255-260.
54. Li S, Gillessen S, Tomasson MH, Dranoff G, Gilliland DG and Van Etten RA. (2001). Blood, 97, 1442-1450.
55. Li S, Ilaria Jr RL, Million RP, Daley GQ and Van Etten RA. (1999). J. Exp. Med., 189, 1399-1412.
56. Lowenberg B, Downing JR and Burnett A. (1999). N. Engl. J. Med., 341, 1051-1062.
57. Manz MG, Miyamoto T, Akashi K and Weissman IL. (2002). Proc. Natl. Acad. Sci. USA, 99, 11872-11877.
58. Mayo MW and Baldwin AS. (2000). Biochim. Biophys. Acta, 1470, M55-62.
59. Mayotte N, Roy D-C, Yao J, Kroon E and Sauvageau G. (2002). Blood, 100, 4177-4184.
60. Mulloy JC, Cammenga J, MacKenzie KL, Berguido FJ, Moore MA and Nimer SD.. (2002). Blood, 99, 15-23.
61. O'Dwyer ME and Druker BJ. (2000). Lancet Oncol., 1, 207-211.
62. Orlowski RZ and Baldwin Jr AS. (2002). Trends Mol. Med., 8, 385-389.
63. Park CH, Bergsagel DE and McCulloch EA. (1971). J. Natl. Cancer Inst., 46, 411-422.
64. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ and Clarke MF. (2003). Nature, 423, 302-305.
65. Passegue E, Jamieson CH, Ailles LE and Weissman IL. (2003). Proc. Natl. Acad. Sci. USA, 100 (Suppl 1), 11842-11849.
66. Perry MC. (2001). The Chemotherapy Source Book 3rd edn. Lippincott Williams and Wilkins: Philadelphia.
67. Ravandi F, Talpaz M, Kantarjian H and Estrov Z. (2002). Br. J. Haematol., 116, 57-77.
68. Reya T, Morrison SJ, Clarke MF and Weissman IL. (2001). Nature, 414, 105-111.
69. Romano MF, Lamberti A, Bisogni R, Tassone P, Pagnini D, Storti G, Del Vecchio L, Turco MC and Venuta S. (2000). Gene Ther., 7, 1234-1237.
70. Ruiter GA, Zerp SF, Bartelink H, van Blitterswijk WJ and Verheij M. (2003). Anticancer Drugs, 14, 167-173.
71. Schofield R. (1983). Biomed. Pharmacother., 37, 375-380.
72. Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE and McCubrey JA. (2004). Leukemia, 18, 189-218.
73. Stirewalt DL, Kopecky KJ, Meshinchi S, Appelbaum FR, Slovak ML, Willman CL and Radich JP. (2001). Blood, 97, 3589-3595.
74. Stucki A, Rivier AS, Gikic M, Monai N, Schapira M and Spertini O. (2001). Blood, 97, 2121-2129.
75. Sunwoo JB, Chen Z, Dong G, Yeh N, Crowl Bancroft C, Sausville E, Adams J, Elliott P and Van Waes C. (2001). Clin. Cancer Res., 7, 1419-1428.
76. Tallman MS, Nabhan C, Feusner JH and Rowe JM. (2002). Blood, 99, 759-767.
77. Tergaonkar V, Pando M, Vafa O, Wahl G and Verma I. (2002). Cancer Cell, 1, 493-503.
78. Testa U, Riccioni R, Diverio D, Rossini A, Lo Coco F and Peschle C. (2004). Leukemia, 18, 219-226.
79. Thorsteinsdottir U, Kroon E, Jerome L, Blasi F and Sauvageau G. (2001). Mol. Cell. Biol., 21, 224-234.
80. Tomasson MH, Sternberg DW, Williams IR, Carroll M, Cain D, Aster JC, Ilaria Jr RL, Van Etten RA and Gilliland DG. (2000). J Clin. Invest., 105, 423-432.
81. Tomasson MH, Williams IR, Li S, Kutok J, Cain D, Gillessen S, Dranoff G, Van Etten RA and Gilliland DG. (2001). Blood, 97, 1435-1441.
82. Turco MC, Romano MF, Petrella A, Bisogni R, Tassone P and Venuta S. (2004). Leukemia, 18, 11-17.
83. Van Etten RA. (2001). Curr. Opin. Hematol., 8, 224-230.
84. Wang CY, Cusack Jr JC, Liu R and Baldwin Jr AS. (1999). Nat. Med., 5, 412-417.
85. Wang JC, Lapidot T, Cashman JD, Doedens M, Addy L, Sutherland DR, Nayar R, Laraya P, Minden M, Keating A, Eaves AC, Eaves CJ and Dick JE. (1998). Blood, 91, 2406-2414.
86. Wierenga PK, Setroikromo R, Kamps G, Kampinga HH and Vellenga E. (2003). Exp. Hematol., 31, 421-427.
87. Wodinsky I, Swiniarski J and Kensler CJ. (1967). Cancer Chemother. Rep., 51, 415-421.
88. Xu Q, Simpson SE, Scialla TJ, Bagg A and Carroll M. (2003). Blood, 102, 972-980.
89. Yuan Y, Zhou L, Miyamoto T, Iwasaki H, Harakawa N, Hetherington CJ, Burel SA, Lagasse E, Weissman IL, Akashi K and Zhang DE. (2001). Proc. Natl. Acad. Sci. USA, 98, 10398-10403.
90. Zhao RC, Jiang Y and Verfaillie CM. (2001). Blood, 97, 2406-2412.
91. Zhao S, Konopleva M, Cabreira-Hansen M, Xie Z, Hu W, Milella M, Estrov Z, Mills GB and Andreeff M. (2004). Leukemia, 18, 267-275.
92. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H and Sorrentino BP. (2001). Nat. Med., 7, 1028-1034.
93. Zhu Z, Hattori K, Zhang H, Jimenez X, Ludwig DL, Dias S, Kussie P, Koo H, Kim HJ, Lu D, Liu M, Tejada R, Friedrich M, Bohlen P, Witte L and Rafii S. (2003). Leukemia, 17, 604-611.